drugset / Trial / NCT06733688

A Study to Evaluate Oral Formulations of Tedizolid Phosphate in Healthy Participants (MK-1986-043)

NCT06733688

Phase 1 Completed 36 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverOpen-labelBasic science

Summary

The goal of the study is to learn what happens to different oral formulations of tedizolid phosphate (MK-1986) in a healthy person's body over time. Researchers want to know if there is a difference in the absorption and elimination of different oral formulations from the healthy person's body.

Timeline

Start
2022-03-23
Primary completion
2022-04-15
Completion
2022-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Tedizolid Phosphate Small molecule Oral

Indications

No indication recorded.